Both simvastatin and VULM 1457 as ACAT inhibitor attenuate the outcome of myocardial ischaemia reperfusion injury by the different mechanisms in diabetic rats with lipid metabolism disorders
A. Adameova, E. Andelova, M. Kuželova, V. Faberová, D. Pancza, J. Styk, A. Ziegelhöffer, T. Ravingerová, P. ŠvecVolume:
40
Year:
2006
Language:
english
DOI:
10.1016/j.yjmcc.2006.03.118
File:
PDF, 64 KB
english, 2006